Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 4257875, 9 pages
https://doi.org/10.1155/2017/4257875
Clinical Study

Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy

1Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
2Department of Endocrinology, Odense University Hospital, Odense, Denmark
3Section of Molecular Diabetes & Metabolism, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
4Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Aalborg, Denmark

Correspondence should be addressed to Jaco Botha; kd.nr@ahtob.j

Received 14 October 2016; Revised 24 November 2016; Accepted 14 December 2016; Published 12 January 2017

Academic Editor: Toshiyasu Sasaoka

Copyright © 2017 Jaco Botha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 365, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar
  2. E. S. Ford, C. Li, and N. Sattar, “Metabolic syndrome and incident diabetes: current state of the evidence,” Diabetes Care, vol. 31, no. 9, pp. 1898–1904, 2008. View at Publisher · View at Google Scholar
  3. A. S. Gami, B. J. Witt, D. E. Howard et al., “Metabolic syndrome and risk of incident cardiovascular events and death,” Journal of the American College of Cardiology, vol. 49, no. 4, pp. 403–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. H. Unger, “Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome,” Endocrinology, vol. 144, no. 12, pp. 5159–5165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. G. Kranendonk, J. A. van Herwaarden, T. Stupkova et al., “Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors,” Atherosclerosis, vol. 239, no. 2, pp. 419–427, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Brand, M. M. Rovers, B. B. Yeap et al., “Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies,” PLoS ONE, vol. 9, no. 7, Article ID e100409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. E. J. Gianatti, P. Dupuis, R. Hoermann et al., “Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial,” Diabetes Care, vol. 37, no. 8, pp. 2098–2107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. V. Magnussen, D. Glintborg, P. Hermann, D. M. Hougaard, K. Højlund, and M. Andersen, “Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy,” Diabetes, Obesity and Metabolism, vol. 18, no. 10, pp. 980–989, 2016. View at Publisher · View at Google Scholar
  9. A. Agouni, A. H. Lagrue-Lak-Hal, P. H. Ducluzeau et al., “Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome,” American Journal of Pathology, vol. 173, no. 4, pp. 1210–1219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Helal, C. Defoort, S. Robert et al., “Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 9, pp. 665–671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Théry, M. Ostrowski, and E. Segura, “Membrane vesicles as conveyors of immune responses,” Nature Reviews Immunology, vol. 9, no. 8, pp. 581–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Zimman and E. A. Podrez, “Regulation of platelet function by class B scavenger receptors in hyperlipidemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 12, pp. 2350–2356, 2010. View at Publisher · View at Google Scholar
  13. H. Adachi and M. Tsujimoto, “Endothelial scavenger receptors,” Progress in Lipid Research, vol. 45, no. 5, pp. 379–404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Kennedy and S. R. Kashyap, “Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes,” Metabolic Syndrome and Related Disorders, vol. 9, no. 4, pp. 239–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Knøsgaard, S. B. Thomsen, M. Støckel, H. Vestergaard, and A. Handberg, “Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals,” Nutrition & Diabetes, vol. 4, article e114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Nielsen, H. Irvine, S. Vedel, B. Raungaard, H. Beck-Nielsen, and A. Handberg, “Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia,” PLoS ONE, vol. 10, no. 4, Article ID e0121516, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Handberg, K. Levin, K. Højlund, and H. Beck-Nielsen, “Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance,” Circulation, vol. 114, no. 11, pp. 1169–1176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Handberg, K. Højlund, A. Gastaldelli et al., “Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population,” Journal of Internal Medicine, vol. 271, no. 3, pp. 294–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Nielsen, H. Beck-Nielsen, M. N. Andersen, and A. Handberg, “A flow cytometric method for characterization of circulating cell-derived microparticles in plasma,” Journal of Extracellular Vesicles, vol. 3, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  20. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a phenotypic switch in adipose tissue macrophage polarization,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. R. Kashyap, A. G. Ioachimescu, H. L. Gornik et al., “Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL,” Obesity, vol. 17, no. 12, pp. 2142–2148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Amabile, S. Cheng, J. M. Renard et al., “Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study,” European Heart Journal, vol. 35, no. 42, pp. 2972–2979, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. N. E. Sunny, E. J. Parks, J. D. Browning, and S. C. Burgess, “Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease,” Cell Metabolism, vol. 14, no. 6, pp. 804–810, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Satapati, N. E. Sunny, B. Kucejova et al., “Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver,” Journal of Lipid Research, vol. 53, no. 6, pp. 1080–1092, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Yatsuya, T. Nihashi, Y. Li et al., “Independent association of liver fat accumulation with insulin resistance,” Obesity Research & Clinical Practice, vol. 8, no. 4, pp. e350–e355, 2014. View at Publisher · View at Google Scholar
  27. N. Ghouri, D. Preiss, and N. Sattar, “Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data,” Hepatology, vol. 52, no. 3, pp. 1156–1161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. M. Mazeaud, F. Driss, K.-H. Le Quan Sang et al., “Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients,” Atherosclerosis, vol. 94, no. 2-3, pp. 201–211, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Icli, F. Aksoy, G. Nar et al., “Increased mean platelet volume in familial hypercholesterolemia,” Angiology, vol. 67, no. 2, pp. 146–150, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. C. J. Boos and G. Y. Lip, “Assessment of mean platelet volume in coronary artery disease—what does it mean?” Thrombosis Research, vol. 120, no. 1, pp. 11–13, 2007. View at Publisher · View at Google Scholar
  31. H. Wang, Z.-H. Wang, J. Kong et al., “Oxidized low-density lipoprotein-dependent platelet- derived microvesicles trigger procoagulant effects and amplify oxidative stress,” Molecular Medicine, vol. 18, no. 2, pp. 159–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Ghosh, G. Murugesan, K. Chen et al., “Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms,” Blood, vol. 117, no. 23, pp. 6355–6366, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Nomura, A. Shouzu, S. Omoto, M. Nishikawa, T. Iwasaka, and S. Fukuhara, “Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes,” Clinical and Applied Thrombosis/Hemostasis, vol. 10, no. 3, pp. 205–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Klop, J. W. F. Elte, and M. C. Cabezas, “Dyslipidemia in obesity: mechanisms and potential targets,” Nutrients, vol. 5, no. 4, pp. 1218–1240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. N. A. Englyst, J. M. Taube, T. J. Aitman, T. P. Baglin, and C. D. Byrne, “A novel role for CD36 in VLDL-enhanced platelet activation,” Diabetes, vol. 52, no. 5, pp. 1248–1255, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Lundman, M. J. Eriksson, A. Silveira et al., “Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1),” American Journal of Cardiology, vol. 91, no. 9, pp. 1128–1131, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Miller, N. J. Stone, C. Ballantyne et al., “Triglycerides and cardiovascular disease: a scientific statement from the american heart association,” Circulation, vol. 123, no. 20, pp. 2292–2333, 2011. View at Publisher · View at Google Scholar
  38. K. Y. Stokes, D. Cooper, A. Tailor, and D. N. Granger, “Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide,” Free Radical Biology and Medicine, vol. 33, no. 8, pp. 1026–1036, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Castoldi, C. Naffah de Souza, N. O. S. Câmara, and P. M. Moraes-Vieira, “The macrophage switch in obesity development,” Frontiers in Immunology, vol. 6, article 637, 2016. View at Publisher · View at Google Scholar
  40. R. Song, “Mechanism of metformin: a tale of two sites,” Diabetes Care, vol. 39, no. 2, pp. 187–189, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. A. M. Isidori, E. Giannetta, E. A. Greco et al., “Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis,” Clinical Endocrinology, vol. 63, no. 3, pp. 280–293, 2005. View at Publisher · View at Google Scholar · View at Scopus